OR WAIT 15 SECS
© 2020 MJH Life Sciences and BioPharm International. All rights reserved.
Cynthia A. Challener, PhD, is a contributing editor to BioPharm International.
July 01, 2020
RNA is easier to manipulate than DNA but challenging to deliver to the right cells.
Identifying the source, assessing the risk, and removing residual impurities requires a strategic approach.
June 01, 2020
Therapies for early and late treatment and passive immunization of COVID-19 are needed and can be developed using antibodies from recovered patients.
May 01, 2020
Next-generation therapeutics and regulatory requirements create demand for complex, fit-for-purpose tests.